Experimental Pathology

Experimental Pathology research in the NYU Department of Pathology traces its roots back to the origins of the Department, which was founded on the principle of investigative pathology. During the tenure of Dr. Lewis Thomas as Chair, research in Immunology flourished in the Department under the rubric of Experimental Pathology. In this period, the proliferation of experimental pathology research increased to such an extent that a separate Program in Immunology was ultimately established. Today, research in the Experimental Pathology Program covers a wide variety of topics, from stem cells to cancer vaccines to parasite immunology to tumor angiogenesis. The common thread uniting these research themes is an emphasis on organismal biology/pathology, with an integrative, holistic focus that is echoed in the philosophy of our Graduate Program in Pathobiology.

Currently funded experimental pathology research in the Department includes: Alzheimer Disease, Alzheimer drug discovery, cerebrovascular amyloidosis; Immunotherapy and breast cancer; Outcomes, early stage, and growth regulation of prostate cancer; Dendritic cell vaccines; Dendritic cell behavior at the maternal/fetal interface; Signaling in lymphocytes and inborn immunodeficiencies; and Sarcoma mouse models. The Department is also home to the Heidelberger Division of Parasite Immunology with researching in parasitology, African tyrpanosomes, plasmodium and other apicomplezan parasites.

Note: The Experimental Pathology Shared Core Facilities provide services for the microscopic analysis of tissues for clinical as well as experimental animal model studies. See our section on the experimental pathology core laboratories for more information.

Related links: